Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amgen (NQ: AMGN )

251.89 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, May 24, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 500
Open 251.89
Bid (Size) 251.04 (1)
Ask (Size) 252.50 (2)
Prev. Close 251.89
Today's Range 251.89 - 251.89
52wk Range 198.64 - 258.45
Shares Outstanding N/A
Dividend Yield 2.79%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Analyst Ratings for Amgen
Analysts have provided the following ratings for Amgen (NASDAQ:AMGN) within the last quarter: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2022
 
Via Benzinga

Performance

YTD
+11.12%
+11.12%
1 Month
-0.11%
-0.11%
3 Month
+13.77%
+13.77%
6 Month
+23.16%
+23.16%
1 Year
+1.67%
+1.67%

More News

Read More
7 Cheap Biotech Stocks to Buy Now
Via InvestorPlace
How Heart Drugs Could Pump $10 Billion Into Merck's Coffers
Via Investor's Business Daily
7 Dividend Stocks to Boost Your Retirement Savings
Via InvestorPlace
Peering Into Amgen's Recent Short Interest
Via Benzinga
5 Beaten-Down Blue-Chip Stocks to Buy Now
Via InvestorPlace
NASDAQ: AMGN Investor Notice: Investigation over Possible Securities Laws Violations by Amgen Inc.
Via SBWire
Executives Sell More Than $220M Of 3 Stocks
Via Benzinga
10 Biggest Price Target Changes For Tuesday
Via Benzinga
Markets Sell Off Following Last Week's Federal Reserve Decision
Via Benzinga
This Is What Whales Are Betting On Amgen
Via Benzinga
Week In Review: OrbiMed Plans To Raise $1.1 Billion For Fifth Asia Fund
Via Talk Markets
Markets Close Turbulent Week On A Down Note
Via Benzinga
9 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
7 Defensive Dividend Healthcare Stocks to Buy Now
Via InvestorPlace
Ongoing Investigation Reminder: The Schall Law Firm Encourages Investors in Amgen Inc. with Losses of $100,000 to Contact the Firm
Via NewMediaWire
Ongoing Investigation Reminder: The Schall Law Firm Encourages Investors in Amgen Inc. with Losses of $100,000 to Contact the Firm
Via NewMediaWire
Ongoing Investigation Alert: The Schall Law Firm Encourages Investors in Amgen Inc. with Losses of $100,000 to Contact the Firm
Via NewMediaWire
INVESTIGATION NOTICE: The Schall Law Firm Encourages Investors in Amgen Inc. with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
Analyzing Amgen's Short Interest
Via Benzinga
The Week Ahead In Biotech (May 1-7): Phathom FDA Decision, Pfizer, Vertex Pharma Lead Earnings News, Ophthalmology Conference Presentations, And More
Via Benzinga
Here's How Much $100 Invested In Amgen 10 Years Ago Would Be Worth Today
Via Benzinga
INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Amgen Inc. with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
Major Indexes Log Best Day Since Early March
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.